1. Market Research
  2. > Pathology Industry

anemia Industry, December 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Blood Disease, Endocrine Disease, Injectable Delivery, Therapy, Erythropoietin, In Vitro Diagnostic Reagent, Biosimilar, Fetal Monitoring, Autoimmune Disease, Bone Marrow Transplant, Point Of Care Testing, Cancer, Clinical Trial, Digestive System Disorder, Infectious Disease, Neurological Disorder, Prefillable Syringe, Protein.


 
1-10 of 91 reports for anemia

Purchase Reports From Reputable Market Research Publishers

Aplastic Anemia - Pipeline Review, H2 2016

Aplastic Anemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H2 2016, provides an overview ...

 Renal Anemia-Pipeline Insights, 2016

Renal Anemia-Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “ Renal Anemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Renal Anemia. The DelveInsight’sReport ...

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, ...

Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

 Anemia-API Insights, 2016

Anemia-API Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuste ...

 Iron Deficiency Anemia-API Insights, 2016

Iron Deficiency Anemia-API Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuste ...

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

 Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2016

Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuste ...

About 7700 reports for anemia

Download Unlimited Documents from Trusted Public Sources

Blood Disease Statistics in the Netherlands

  • September 2016
    184 pages
  • Blood Disease  

  • Netherlands  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.